FY 2019 REVENUES
REVENUES GROWTH IN FY 2019
ONCOLOGY ORDERS GROWTH IN FY 2019
NON-GAAP EPS 1 GROWTH IN FY 2019
Fourth Quarter 2020 Summary Oncology Systems gross orders of $1.0 billion, down 8% in dollars or 10% in constant currency 10 Ethos™ orders received, including 5 in North America and 5 in EMEA...
Varian (NYSE: VAR) congratulates the United States Trade Representative and the Ministry of Development, Industry and Foreign Trade of Brazil on achieving the first steps of a trade agreement...
Varian (NYSE: VAR), a leading provider of cancer care technologies and solutions, continues to reinforce its commitment to delivering Intelligent Cancer Care™ during the 2020 American Society...
Varian (NYSE: VAR) today announced its fourth quarter of fiscal year 2020 earnings release date. The Company will report results for the fourth quarter of fiscal year 2020 after market close on...
View all press releases
View all events
In light of the pending transaction with Siemens Healthineers, Varian will not be hosting a conference call for its fourth quarter of fiscal year 2020 earnings.
Canceled Third Quarter Conference Call in Light of Pending Transaction with Siemens Healthineers
View more events
Q3 FY20 Earnings Results
View all quarterly results
FY19 Annual Report
FY19 Sustainability Report
View all reports
VP, Treasurer and Investor Relations
1 650 424 6081
Varian Corporate Headquarters
3100 Hansen Way
Palo Alto, CA 94304-1038
Stay up to date on the latest investor information.